BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 16918051)

  • 21. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R; Shiraishi K; Iwase S; Ohtomo K; Nakagawa K
    Breast Cancer; 2015 Nov; 22(6):657-63. PubMed ID: 24756246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.
    FitzSullivan E; Bassett RL; Kuerer HM; Mittendorf EA; Yi M; Hunt KK; Babiera GV; Caudle AS; Black DM; Bedrosian I; Reyna C; Teshome M; Meric-Bernstam F; Hwang R
    Ann Surg Oncol; 2017 Mar; 24(3):652-659. PubMed ID: 27822630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast-conserving surgery in breast cancer.
    Tenea Cojan TS; Vidrighin CD; Ciobanu M; Paun I; Teodorescu M; Mogos G; Tenovici M; Florescu M; Mogos D
    Chirurgia (Bucur); 2012; 107(5):616-25. PubMed ID: 23116836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
    Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
    J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary radiotherapy in conservative surgery for early-stage breast cancer (stage I and II).
    García Novoa A; Acea Nebril B; Díaz I; Builes Ramírez S; Varela C; Cereijo C; Mosquera Oses J; López Calviño B; Seoane Pillado MT
    Cir Esp; 2016; 94(6):331-8. PubMed ID: 27256280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
    Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
    Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer.
    Janjan NA; Murray KJ; Conway P; Walker A; Wilson JF
    Cancer; 1992 Jun; 69(11):2842-8. PubMed ID: 1571915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer.
    Arriagada R; Lê MG; Contesso G; Guinebretière JM; Rochard F; Spielmann M
    Ann Oncol; 2002 Sep; 13(9):1404-13. PubMed ID: 12196366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
    Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
    Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients.
    Haffty BG; McKhann C; Beinfield M; Fischer D; Fischer JJ
    Arch Surg; 1993 Dec; 128(12):1315-9; discussion 1319. PubMed ID: 8250703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
    Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
    J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.